Chinook Tyee Industry Ltd Stock Toronto S.E.
Equities
GBI.H
CA16961T2083
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 322K 237K |
---|---|---|---|---|---|
Net income 2022 | -1M -735K | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net Debt 2022 | 3.15M 2.31M | Net Debt 2023 | 2.77M 2.03M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.79
x | P/E ratio 2023 |
-1.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.11% |
Managers | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 12-12-13 |
Director/Board Member | 72 | 18-12-04 | |
Investor Relations Contact | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 12-12-13 |
Director/Board Member | 72 | 18-12-04 | |
Frank Otto
BRD | Director/Board Member | - | 22-05-10 |
1st Jan change | Capi. | |
---|---|---|
+45.15% | 6.34B | |
-14.00% | 4.61B | |
+9.54% | 3.39B | |
-8.99% | 3.29B | |
+50.03% | 2.02B | |
-6.97% | 1.73B | |
-0.31% | 1.67B | |
+50.00% | 1.63B | |
-10.61% | 1.59B |